Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma
Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma, a speaker at the marcus evans Discovery Summit 2013, on the importance of collaboration between the pharmaceutical industry and academia.
Similar to Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma
Similar to Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma (20)
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma
1. Moving with the Times for
Better Drug Development
comes to finding ways to implement and How can pharmaceutical models
transfer new ideas through the better deliver to market?
pharmaceutical process. Combining
these two strengths increases The increasing cost of developing
productivity and decreases the time compounds from idea to market is a
needed for ideas to become tangible major issue at the moment. Firm
drugs in the market. decisions must be made on whether to
cease development of projects before
What best practices provide true they become very expensive. This way
medical value? costs can be better controlled and the
outcome of clinical trials more positive.
As the industry is proceeding into more
of a collaboration mode, it is important
Interview with: Hasse Kromann, that scientists be able to work across
Head of Section R&D Partnership culture groups, industries and barriers.
Management, Innovation &
Research, LEO Pharma They should come out from behind their
desks and really look at patient needs.
This will spark innovation and provide
The industry
Drug discovery can create true
medical value when scientists work
them with the inspiration needed to
come up with bright ideas for new should be
adaptable
across cultural groups and focus on products that meet real-life needs.
patient needs and problems, says Hasse
Kromann, Head of Section R&D How can open innovation platforms
and able to
Partnership Management, Innovation & be designed to deliver compounds
Research, LEO Pharma. “This will spark to the clinic in the future?
innovation and provide them with the
inspiration needed to come up with
bright ideas for new products,” he adds.
The industry is currently experimenting
with different platforms and ways of
collaborating with biotech and academic
identify
A speaker at the marcus evans
Discovery Summit 2013, in Monte
institutions to run fast exploratory
clinical trials. which models
work best
Carlo, Monaco, 21 - 22 March, Kromann
discusses why proving concepts earlier When this is achieved, the discovery
on in drug development will save and clinical work will be bridged and
in specific
costs. patients’ needs and problems can then
take centre stage.
Why is close cooperation between
industry and academia so important
to drug discovery?
Different platforms will suit different
clinical objectives. projects
The pharmaceutical industry has the
ability to develop new drugs and
The industry should be adaptable and
able to identify which models work best or issues
academia is very innovative when it for specific projects or issues.
2. The Pharma Network – marcus About the Discovery Summit 2013
evans Summits group delivers
peer-to-peer information on This unique forum will take place at Le Méridien Beach Plaza, Monte Carlo, Monaco,
strategic matters, professional 21 - 22 March, 2013. Offering much more than any conference, exhibition or trade
trends and breakthrough show, this exclusive meeting will bring together esteemed industry thought leaders
innovations. and solution providers to a highly focused and interactive networking event. The
Summit includes presentations and interactive forums on building bridges from pre-
clinical to clinical studies and designing open innovation platforms.
www.discovery-summit.com
Please note that the Summit is a
closed business event and the Contact
number of participants strictly
limited. Maria Gregoriou, Journalist, marcus evans, Summits Division
Tel: + 357 22 849 400
Email: press@marcusevanscy.com
For more information please send an email to info@marcusevanscy.com
All rights reserved. The above content may be republished or reproduced. Kindly
inform us by sending an email to press@marcusevanscy.com
About marcus evans Summits
marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss
strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to
individually tailor their schedules of keynote presentations, think tanks, seminars and one-to-one business meetings.
For more information, please visit: www.marcusevans.com
Upcoming Events
Evolution Summit (North America) - www.evolutionsummit.com
Evolution Summit (Europe) - www.evolution-summit.com
To view the web version of this interview, please click here: www.discovery-summit.com/HasseKromann